U.S.-based companies announced more than 153,000 job cuts in October, the research firm Challenger, Gray…
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the…
